We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Biopsies Do Not Promote Cancer Spread

By HospiMedica International staff writers
Posted on 20 Jan 2015
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) does not cause pancreatic cancer to extend, according to a new study.

Researchers at the Mayo Clinic (Jacksonville, FL, USA) conducted a study involving 2,034 patients with locoregional pancreatic cancer who underwent curative intent surgery from 1998 to 2009; of these, 498 (24%) patients received EUS-FNA within the peri-diagnostic period (EUS-FNA group). The other 1,536 patients who did not receive EUS evaluation, or who underwent EUS without FNA, were included in the non-EUS-FNA group. Overall survival and pancreatic cancer-specific survival were compared after controlling for relevant covariates.

The results showed that during a mean follow-up time of 21 months, 285 patients (57%) in the EUS-FNA group and 1,167 patients (76%) in the non-EUS-FNA group died. Pancreatic cancer was identified as the cause of death for 251 patients (50%) in the EUS-FNA group and 980 patients (64%) in the non-EUS-FNA group. After controlling for age, race, gender, tumor histology, tumor stage, tumor grade, tumor location, radiation, chemotherapy, and other factors, EUS-FNA was marginally associated with improved overall survival, but did not affect cancer-specific survival. The study was published online on January 9, 2015, in Gut.

“Biopsies offer very valuable information that allow us to tailor treatment; in some cases, we can offer chemotherapy and radiation before surgery for a better outcome, and in other cases, we can avoid surgery and other therapy altogether,” said senior author, gastroenterologist Prof. Michael Wallace, MD, MPH. “Physicians and patients should feel reassured that a biopsy is very safe. We do millions of biopsies of cancer a year in the US, but one or two case studies have led to this common myth that biopsies spread cancer.”

During EUS-FNA, a flexible endoscope is inserted into the patient's body through the mouth or the anus. The tip of the endoscope has a small rotating ultrasound system that can peer about 10 cm into surrounding tissue. When the site that needs to be biopsied has been located, a fine needle is inserted down a canal in the endoscope and inserted into the area. Several samples of tissue are then retrieved and examined by a pathologist who is often in the room during the procedure.

Related Links:

Mayo Clinic



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Multilevel Self-Loading Stretcher
CARRERA XL

Latest Surgical Techniques News

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices